A phase Ib trial of JX-594 (Pexa-Vec), a targeted multimechanistic oncolytic vaccinia virus, in combination with low-dose cyclophosphamide in patients with advanced solid tumors
Maud Toulmonde, et al. ESMO 2017, September 11, 2017, 13:15 [...]
Maud Toulmonde, et al. ESMO 2017, September 11, 2017, 13:15 [...]
Laetitia Fend, et al. Cancer Research, July 2017, DOI: 10.1158/0008-5472.CAN-16-2165 [...]
Sandrine Cochin, et al. CLARA, Forum de la recherche en [...]
Laetitia Fend, et al. AACR, American Association for cancer Research, [...]
Faleh Husseini, et al. Annals of Oncology, February 2017, DOI: [...]
Johann Foloppe, et al. 10th International Meeting on Replicating Oncolytic [...]
Jean Baptiste Marchand, et al. XXI International Poxvirus, Asfavirus and [...]
Marine Ricordel, et al. XXI International Poxvirus, Asfavirus and Iridovirus [...]
Johann Foloppe, et al. XXI International Poxvirus, Asfavirus and Iridovirus [...]